We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-20.33%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$12B
AUM Growth
-$2.98B
Cap. Flow
+$613M
Cap. Flow %
5.11%
Top 10 Hldgs %
28.69%
Holding
863
New
191
Increased
291
Reduced
251
Closed
118

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$150M
2
DGX icon
Quest Diagnostics
DGX
+$142M
3
USB icon
US Bancorp
USB
+$135M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$130M
5
SBUX icon
Starbucks
SBUX
+$103M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$151M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$99.6M
3
BKNG icon
Booking.com
BKNG
+$96.9M
4
HUM icon
Humana
HUM
+$96.4M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$89.7M

Sector Composition

Rank Sector Weight
1 Technology 24.61%
2 Healthcare 19.51%
3 Financials 13.3%
4 Consumer Discretionary 10.41%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.87T
$543M 4.53%
3,442,202
-545,188
-14% -$89.7M
AAPL icon
2
Apple
AAPL
$4.77T
$430M 3.58%
6,762,192
-345,616
-5% -$25.4M
UNH icon
3
UnitedHealth
UNH
$384B
$364M 3.04%
1,459,485
-91,341
-6% -$25.1M
ORCL icon
4
Oracle
ORCL
$351B
$336M 2.81%
6,960,330
-1,504,768
-18% -$77.7M
BABA icon
5
Alibaba
BABA
$270B
$327M 2.73%
1,680,573
-148,200
-8% -$30.9M
JNJ icon
6
Johnson & Johnson
JNJ
$628B
$305M 2.54%
2,326,857
-318,681
-12% -$45.2M
MDT icon
7
Medtronic
MDT
$106B
$293M 2.44%
3,246,370
-52,341
-2% -$5.57M
USB icon
8
US Bancorp
USB
$99B
$286M 2.38%
8,295,962
+2,807,919
+51% +$135M
KO icon
9
Coca-Cola
KO
$348B
$284M 2.37%
6,421,304
+2,784,716
+77% +$150M
ACN icon
10
Accenture
ACN
$87.4B
$272M 2.27%
1,667,176
+106,688
+7% +$20.6M
MRK icon
11
Merck
MRK
$322B
$234M 1.96%
3,193,363
-827,734
-21% -$65.1M
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.92T
$233M 1.95%
4,016,340
-175,920
-4% -$11.9M
ELV icon
13
Elevance Health
ELV
$81.9B
$230M 1.92%
1,013,022
+35,945
+4% +$9.8M
WFC icon
14
Wells Fargo
WFC
$261B
$228M 1.9%
7,949,108
+1,610,470
+25% +$68.5M
CSCO icon
15
Cisco
CSCO
$447B
$223M 1.86%
5,667,060
+1,500,738
+36% +$65.8M
MMM icon
16
3M
MMM
$87.5B
$220M 1.83%
1,925,815
-103,555
-5% -$13.6M
META icon
17
Meta Platforms (Facebook)
META
$1.54T
$218M 1.82%
1,307,870
+73,997
+6% +$14.5M
AXP icon
18
American Express
AXP
$220B
$214M 1.79%
2,501,194
+52,801
+2% +$6.14M
TJX icon
19
TJX Companies
TJX
$168B
$208M 1.74%
4,356,759
+683,387
+19% +$39.3M
GOOG icon
20
Alphabet (Google) Class C
GOOG
$3.91T
$207M 1.73%
3,562,600
-1,467,360
-29% -$99.6M
TXN icon
21
Texas Instruments
TXN
$257B
$199M 1.66%
1,991,937
-167,978
-8% -$20.2M
LLY icon
22
Eli Lilly
LLY
$1.06T
$185M 1.54%
1,332,388
-450,536
-25% -$61.9M
IEMG icon
23
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$168M 1.4%
4,162,207
+2,657,026
+177% +$130M
CTSH icon
24
Cognizant
CTSH
$20.8B
$150M 1.25%
3,222,311
+3,790
+0.1% +$226K
PM icon
25
Philip Morris
PM
$300B
$143M 1.19%
1,961,612
-494,166
-20% -$40.7M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2020 Portfolio in Review

As of Q1 2020, Grantham, Mayo, Van Otterloo & Co (GMO) held 863 positions worth $12B, down 20% from $15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $613M of net new capital in Q1 2020, opening 191 new positions and adding to 291 existing holdings. Its largest new stake was Quest Diagnostics: 1,373,100 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $99.6M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2020 buy was Quest Diagnostics: 1,373,100 shares worth $110M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Coca-Cola in Q1 2020, an estimated $150M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2020 reduction was Alphabet (Google) Class C, cutting an estimated $99.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Mastercard in Q1 2020, selling an estimated $151M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 29% of its $12B portfolio in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 191 new positions and closed 118 in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 20% quarter-over-quarter to $12B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2020, filed 14 May 2020.